Cell
Therapies
+
All Cell Therapy Services
Plasmid Engineering
Cell Banking
TESSA® Technology
XOFLX™ Cell Lines
Cell Line Development
Technology Transfer
Cell Therapy Process & Analytical Development
Cell Therapy GMP Manufacturing
Viral
Vectors
+
All Viral Vector Services
Plasmid Engineering
Cell Banking
TESSA® Technology
XOFLX™ Cell Lines
Cell Line Development
Viral Vector Process Development
Viral Vector GMP Manufacturing
Biologics &
CGT Testing
+
Minaris Advanced Testing
Testing Services
+
Testing Services Overview
Analytical Development
Assay Transfer
Biosafety Testing
Cell Line Characterization
Lot Release
Potency
Stability
Viral Clearance
Testing by Modality
Minaris Advanced Testing Facilities
Minaris Advanced Testing Leadership
Minaris Advanced Testing History
Minaris Advanced Testing Resource Center
Submit a Sample
Regulatory
& CMC
+
Quality
Regulatory Support
Technologies
& Platforms
+
Viral Vector Technologies
Cell Therapy Technologies
Testing Technologies
About
Us
+
The Minaris Story
Global Footprint for Local Manufacture
Leadership
Announcements & Events
Careers
Knowledge
Center
Contact Us
Enter a term to search
Search for:
Announcements
& Events
Announcements
Events
Announcements
Minaris Technology Adopted for NEDO Program
Read More
Announcements
Minaris Announces Business Alliance with CellTech
Read More
Announcements
Minaris Announces Business Alliance with Myoridge
Read More
Announcements
Iovance Approval of Amtagvi
Read More
Announcements
TESSA Licensing Agreement with Janssen
Read More
Announcements
Ticaros Receives Clinical Approval in Korea
Read More
Announcements
Cabaletta Bio Announces Expansion of GMP Manufacturing Agreement to Include CABA-201
Read More
Announcements
First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, NJ.
Read More
Announcements
Minaris Announces Business Alliance with VectorBuilder Inc.
Read More
Pages:
1
2
3
4
5
See More Announcements & Events
